These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ, Heavens RP, McBride CS. Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784 [Abstract] [Full Text] [Related]
7. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs. Youngster SK, Sonsalla PK, Sieber BA, Heikkila RE. J Pharmacol Exp Ther; 1989 Jun 08; 249(3):820-8. PubMed ID: 2786564 [Abstract] [Full Text] [Related]
8. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor. Sagi Y, Weinstock M, Youdim MB. J Neurochem; 2003 Jul 08; 86(2):290-7. PubMed ID: 12871570 [Abstract] [Full Text] [Related]
9. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B. Finnegan KT, Irwin I, Delanney LE, Langston JW. J Pharmacol Exp Ther; 1995 May 08; 273(2):716-20. PubMed ID: 7752075 [Abstract] [Full Text] [Related]
10. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC. Nature; 1995 May 08; 311(5985):467-9. PubMed ID: 6332989 [Abstract] [Full Text] [Related]
13. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+. Shen RS, Abell CW, Gessner W, Brossi A. FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242 [Abstract] [Full Text] [Related]
14. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP. Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE. Eur J Pharmacol; 1988 Feb 09; 146(2-3):313-8. PubMed ID: 3131149 [Abstract] [Full Text] [Related]
15. Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat. Desole MS, Esposito G, Fresu L, Migheli R, Enrico P, Miele M, De Natale G, Miele E. Neurosci Lett; 1993 Oct 29; 161(2):121-3. PubMed ID: 7903798 [Abstract] [Full Text] [Related]
20. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP. Hemrick-Luecke SK, Robertson DW, Krushinski JH, Fuller RW. Life Sci; 1992 Dec 29; 50(8):573-82. PubMed ID: 1736028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]